Literature DB >> 1205452

The isolation of the urogastrones - inhibitors of gastric acid secretion - from human urine.

H Gregory, I R Willshire.   

Abstract

It has been known for over thirty years that extracts of human urine could cause inhibition of gastric acid secretion. The active principle was called urogastrone and this has now been isolated using a series of twelve simple stages of partition, gel and ion-exchange chromatography. In fact two products were obtained, each in a yeild of less than 1 mg per 1 000 l urine, which represented an overall recovery of 3 - 5%. These materials were biologically indistinguishable, causing inhibition of gastric acid secretion in a variety of circumstances at doses of less than 1 mug/kg. The purified urogastrones were found to be acidic polypeptides composed of 53 and 52 amino acid residues with three internal disulphide bonds, and they differed by only one arginine residue. Neither threonine nor phenylalanine residues were present in the urogastrones.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1205452     DOI: 10.1515/bchm2.1975.356.2.1765

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  10 in total

1.  Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes.

Authors:  James M Mullin; James M Leatherman; Mary Carmen Valenzano; Erika Rendon Huerta; Jon Verrechio; David M Smith; Karen Snetselaar; Mantao Liu; Mary Kay Francis; Christian Sell
Journal:  Mol Biol Cell       Date:  2005-09-21       Impact factor: 4.138

2.  Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands.

Authors:  P U Heitz; M Kasper; S van Noorden; J M Polak; H Gregory; A G Pearse
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

3.  Sex differences in duodenal ulcer.

Authors: 
Journal:  Br Med J       Date:  1979-03-10

4.  Chemical synthesis and cloning of a gene for human beta-urogastrone.

Authors:  J Smith; E Cook; I Fotheringham; S Pheby; R Derbyshire; M A Eaton; M Doel; D M Lilley; J F Pardon; T Patel; H Lewis; L D Bell
Journal:  Nucleic Acids Res       Date:  1982-08-11       Impact factor: 16.971

5.  The source of urinary epidermal growth factor in humans.

Authors:  C Callegari; N P Laborde; G Buenaflor; C G Nascimento; J A Brasel; D A Fisher
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

6.  Secretion of protein and epidermal growth factor (EGF) by transplanted human pancreas.

Authors:  J W Konturek; M Buesing; U T Hopt; J Stachura; H D Becker; S J Konturek
Journal:  Int J Pancreatol       Date:  1992-08

7.  Chemical synthesis of a gene for human epidermal growth factor urogastrone and its expression in yeast.

Authors:  M S Urdea; J P Merryweather; G T Mullenbach; D Coit; U Heberlein; P Valenzuela; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.

Authors:  Y Oka; D N Orth
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

9.  Isolation and partial characterization of canine epidermal growth factor/urogastrone.

Authors:  R Kobayashi; J R Reeve; J H Walsh
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

10.  Cellular and molecular mechanisms of intestinal fibrosis.

Authors:  Silvia Speca; Ilaria Giusti; Florian Rieder; Giovanni Latella
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.